Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Schedule of Common Stock Warrant Activity (Details)

v3.21.1
Stockholders' Equity - Schedule of Common Stock Warrant Activity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at beginning | shares 3,082,987
Exercised | shares (1,150,647)
Outstanding at ending | shares 1,932,340
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Exercise Price [Roll Forward]  
Outstanding at beginning | $ / shares $ 3.82
Exercised | $ / shares 2.31
Outstanding at ending | $ / shares $ 4.72
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]  
Outstanding at beginning | $ $ 37,379
Outstanding at ending | $ $ 31,778